Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-19-000233
Filing Date
2019-02-13
Accepted
2019-02-13 17:12:13
Documents
2
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 4331
2 POWER OF ATTORNEY FOR VERASTEM, INC. BY MICHAEL KAUFFMAN poa_020419-verastem.htm EX-24 6652
  Complete submission text file 0000904454-19-000233.txt   12375
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Reporting) CIK: 0001364719 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35403 | Film No.: 19598581

Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations